Skip to Main Content

Paper Details

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.
Nat Commun
53
2021
B cell, B2M, BRCA2, ICB, PLA2G2D, Patients, T, T cell, advanced solid tumors, cancer, circulating tumor DNA, ctDNA, genes, metastatic tumors, myeloid cell populations, patients, pembrolizumab, phospholipase, tumor, tumor genome, whole
Author NameAffiliation
Jeff P BrucePrincess Margaret Cancer Centre, University Health Network
Samah El GhamrasniPrincess Margaret Cancer Centre, University Health Network
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network
Philippe L BedardPrincess Margaret Cancer Centre, University of Health Network, University of Toronto
Hal K BermanPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsVector Institute
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsOntario Institute for Cancer Research
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsOntario Institute for Cancer Research
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsVector Institute
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network
Lillian L SiuPrincess Margaret Cancer Centre, University of Health Network, University of Toronto
Trevor J PughUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughOntario Institute for Cancer Research
Trevor J PughUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughOntario Institute for Cancer Research
  • 1 - 23

Datasets

Release 1.2